With assistance from USP's Promoting the Quality of Medicines (PQM) program, Guatemala’s official medicines control laboratory has retained their ISO 17025 accreditation, a major milestone in its quest to combat the proliferation of poor quality medicines within its borders.
Global food and dietary supplement experts to gather Dec. 3–4 for workshop on economically motivated adulterationa and fraud. Organized by USP, American Botanical Council, and Food Protection and Defense Institute, the event will feature new tools and standards for identification and mitigation.
New USP Food Fraud Mitigation Guidance aims to help manufacturers and regulators identify ingredients most vulnerable to fraud in their supply chains and choose effective mitigation tools to combat economically-motivated adulteration.
October is Talk About Your Medicines Month. Sponsored by NCPIE, a USP Convention member organization, this annual opportunity encourages patients and healthcare providers to engage in conversation about medications and their safe use, safe storage, and safe disposal.
Pictograms, a free resource from USP, are simple illustrations that help ensure proper medication use for low-literacy and non-native language speaking patients. They provide healthcare professionals with a useful tool to overcome communication and comprehension issues that may arise.
Gigi Davidson, R.Ph., DICVP, Chair of USP's Compounding Expert Committee shares her thoughts and background information on proposed revisions to <797> Pharmaceutical Compounding—Sterile Preparations. Compounding practitioners are encouraged to view and share comments on the changes online.
Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field.
Anita Szajek, Ph.D., principal scientific liaison to USP’s Expert Panel on Therapeutic Peptides, examines therapeutic peptides, the transition from recombinant to synthetic manufacturing routes, and regulatory and quality-related questions.